Unusual presentation of autoimmune pancreatitis type 1

被引:3
|
作者
Linhart, T. [1 ]
Goerg, C. [2 ]
Moll, R. [3 ]
Gress, T. M. [1 ]
机构
[1] Univ Klinikum Giessen & Marburg, Innere Med Klin, D-35033 Marburg, Germany
[2] Univ Klinikum Giessen & Marburg, Innere Med Klin, Standort Marburg, Germany
[3] Univ Klinikum Giessen & Marburg, Inst Pathol, Standort Marburg, Germany
关键词
autoimmune pancreatitis; autoimmune cholangitis; IgG4; CHOLANGITIS; DISEASE; COMPLEX;
D O I
10.1055/s-0030-1262458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: A-51-year-old man presented with increasingly severe upper abdominal pain, in reduced general state and mild weight loss. Ten years before the patient had undergone a Kausch-Whipple procedure (pancreaticoduodenectomy) for an inflammatory mass in the pancreas, at that time histologically identified as an inflammatory tumour with chronic pancreatitis. Since then he has had repeated episodes of stenosis of the biliary-digestive anastomosis, associated with acute cholangitis. Laboratory findings on admission revealed liver function tests that were moderately (AST, ALT) or markedly elevated (GGT and AP). Investigations: Abdominal ultrasound revealed cuffing of the portal vein and its side-branches with low echogenicity. Magnetic resonance imaging showed periportal edema with irregular bile ducts. Initially the histological examination strongly suggested a peripheral malignant T-cell lymphoma. However, subsequent examination revealed a chronic IgG4-associated, lymphoplasmatic sclerosing inflammation of the biliary tract. Treatment and course: Histological re-examination of the 10-year-old pancreatic resection specimens also showed severe lymphoplasmatic infiltrates suggesting a pancreatic manifestation of an IgG4-associated systemic disease (ISD), known nowadays as an type 1 autoimmune pancreatitis (AIP). Based on the initial diagnosis of an invasive periphere malignant T-cell lymphoma of the liver a pre-phase treatment with vincristine, prednisolone followed by one cycle of CHOEP were administered. This resulted in complete remission of the patient's symptoms. Once the true diagnosis had been revised this treatment was immediately stopped. Since the patient remained symptomfree, the initially elevated laboratory parameters returned to normal and a remission of low echogenicity cuffing of the portal vein was observed and no further steroid treatment was administered. Ursodesocycholic acid was then given as the only drug, to prevent any further episodes of cholangitis. Conclusions: Autoimmune pancreatitis continues to be frequently unrecognized in clinical practice. But because it responds well to corticosteroids, this clinical entity should be considered in the differential diagnosis of unclear inflammatory changes and strictures of the pancreatic and biliary tracts or even, if necessary, looked for retrospectively in resected pancreas specimens.
引用
收藏
页码:1662 / 1666
页数:5
相关论文
共 50 条
  • [31] Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis
    Maire, Frederique
    Le Baleur, Yann
    Rebours, Vinciane
    Vullierme, Marie Pierre
    Couvelard, Anne
    Voitot, Helene
    Sauvanet, Alain
    Hentic, Olivia
    Levy, Philippe
    Ruszniewski, Philippe
    Hammel, Pascal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01): : 151 - 156
  • [32] Kidney Involvement in Patients with Type 1 Autoimmune Pancreatitis
    Vujasinovic, Miroslav
    Mucelli, Raffaella Maria Pozzi
    Valente, Roberto
    Verbeke, Caroline Sophie
    Haas, Stephan L.
    Lohr, J-Matthias
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02):
  • [33] Involvement of Basophils in Patients With Type 1 Autoimmune Pancreatitis
    Yanagawa, M.
    Uchida, K.
    Okazaki, K.
    PANCREAS, 2018, 47 (10) : 1435 - 1435
  • [34] Regulatory B Cells in Type 1 Autoimmune Pancreatitis
    Sumimoto, Kimi
    Uchida, Kazushige
    Mitsuyama, Toshiyuki
    Fukui, Yuri
    Kusuda, Takeo
    Miyoshi, Hideaki
    Fukata, Norimasa
    Koyabu, Masanori
    Sakaguchi, Yutaku
    Ikeura, Tsukasa
    Shimatani, Masaaki
    Fukui, Toshiro
    Matsushita, Mitsunobu
    Takaoka, Makoto
    Nishio, Akiyoshi
    Okazaki, Kazuichi
    GASTROENTEROLOGY, 2014, 146 (05) : S297 - S297
  • [35] RITUXIMAB AS MAINTENANCE THERAPY IN TYPE 1 AUTOIMMUNE PANCREATITIS
    Marconato, Eugenio
    de Marchi, Giulia
    De Pretis, Nicolo
    Amodio, Antonio
    Gabrieletto, Enrico Maria
    Mottes, Martina Cattani
    Frulloni, Luca
    GASTROENTEROLOGY, 2022, 162 (07) : S570 - S570
  • [36] Unusual cardiac presentation in neurofibromatosis type 1
    Moustafa, Sherif
    Patton, David J.
    Connelly, Michael S.
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (12): : 972 - 972
  • [37] An Unusual Presentation of Seronegative Autoimmune Hepatitis
    Verma, Gagan
    Meyer, Adam
    Mizrahi, Joseph
    Sun, Edward
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2112 - S2113
  • [38] Regulatory T Cells in Type 1 Autoimmune Pancreatitis
    Uchida, Kazushige
    Kusuda, Takeo
    Koyabu, Masanori
    Miyoshi, Hideaki
    Fukata, Norimasa
    Sumimoto, Kimi
    Fukui, Yuri
    Sakaguchi, Yutaku
    Ikeura, Tsukasa
    Shimatani, Masaaki
    Fukui, Toshiro
    Matsushita, Mitsunobu
    Takaoka, Makoto
    Nishio, Akiyoshi
    Okazaki, Kazuichi
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [39] Unusual presentation of primary autoimmune neutropenia
    Murphy, PT
    Casey, MC
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) : 214 - 215
  • [40] Autoimmune Pancreatitis Type 1 Associated with a Pancreatic Pseudocyst
    Hesse, Felix
    Braren, Rickmer
    Schmid, Roland M.
    Phillip, Veit
    CASE REPORTS IN GASTROENTEROLOGY, 2019, 13 (01) : 195 - 199